-
-
7 . Periodical
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
- 저자
- by Wells, Athol U; Flaherty, Kevin R; Brown, Kevin K; Inoue, Yoshikazu; Devaraj, Anand, et al.
- 소스
- The Lancet Respiratory Medicine; May 2020, Vol. 8 Issue: 5 p453-460, 8p
-